FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385648859> ?p ?o ?g. }

• W4385648859 endingPage "121" @default.
• W4385648859 startingPage "113" @default.
• W4385648859 abstract "Clinical trials confirmed the beneficial effects of adding pertuzumab (P) to the combination of trastuzumab-chemotherapy (TC) in the (neo)adjuvant setting of high-risk HER2-positive early breast cancer (HER2+BC). We evaluated the clinical, economic and societal impact of adding pertuzumab to neoadjuvant TC combination (TPC) in Italy.A cost-consequence analysis comparing TPC vs. TC was performed developing a cohort-based multi-state Markov model to estimate the clinical, societal and economic impact of the neoadjuvant therapy of TPC versus TC in HER2+BC at high-risk of recurrence. The model works on a cycle length of 1 month and 5-years-time horizon. Literature review-based data were used to populate the model. The following clinical and economic outcomes were estimated: cumulative incidence of loco-regional/distant recurrences, life of years and QALY and both direct and indirect costs (€). Finally, sensitivity analyses were performed.TPC was associated with a 75,630 € saved of direct costs. Specifically, it was associated with an initial increase of treatment costs (+4.8%) followed by reduction of recurrence management cost (-20.4%). TPC was also associated with an indirect cost reduction of 1.40%, as well as decreased incidence of distant recurrence (-20.14%), days of work lost (-1.53%) and days lived with disability (-0.50%). Furthermore, TPC reported 10,47 QALY gained (+2.77%) compared to TC. The probability to achieve the pathological complete response (pCR) was the parameter that mostly affected the results in the sensitivity analysis.Our findings suggested that TPC combination could be a cost-saving option in patients with HER2+BC at high-risk of recurrence." @default.
• W4385648859 created "2023-08-09" @default.
• W4385648859 creator A5001910485 @default.
• W4385648859 creator A5020078965 @default.
• W4385648859 creator A5031414207 @default.
• W4385648859 creator A5035471408 @default.
• W4385648859 creator A5038355731 @default.
• W4385648859 creator A5039980470 @default.
• W4385648859 creator A5041668420 @default.
• W4385648859 creator A5046959234 @default.
• W4385648859 creator A5079560019 @default.
• W4385648859 creator A5083047069 @default.
• W4385648859 date "2023-10-01" @default.
• W4385648859 modified "2023-10-14" @default.
• W4385648859 title "A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy" @default.
• W4385648859 cites W1987326983 @default.
• W4385648859 cites W2013029269 @default.
• W4385648859 cites W2020677481 @default.
• W4385648859 cites W2035214881 @default.
• W4385648859 cites W2057615228 @default.
• W4385648859 cites W2062638219 @default.
• W4385648859 cites W2075894019 @default.
• W4385648859 cites W2090108443 @default.
• W4385648859 cites W2095861620 @default.
• W4385648859 cites W2123591186 @default.
• W4385648859 cites W2137228442 @default.
• W4385648859 cites W2143025931 @default.
• W4385648859 cites W2147060536 @default.
• W4385648859 cites W2147415463 @default.
• W4385648859 cites W2159967578 @default.
• W4385648859 cites W2315066014 @default.
• W4385648859 cites W2585697071 @default.
• W4385648859 cites W2590877603 @default.
• W4385648859 cites W2624590002 @default.
• W4385648859 cites W2625993296 @default.
• W4385648859 cites W2766084386 @default.
• W4385648859 cites W2768649895 @default.
• W4385648859 cites W2787493028 @default.
• W4385648859 cites W2788360694 @default.
• W4385648859 cites W2791139688 @default.
• W4385648859 cites W2810609012 @default.
• W4385648859 cites W2896597060 @default.
• W4385648859 cites W2897638555 @default.
• W4385648859 cites W2902218997 @default.
• W4385648859 cites W2912993657 @default.
• W4385648859 cites W2921099093 @default.
• W4385648859 cites W2969972205 @default.
• W4385648859 cites W2995808512 @default.
• W4385648859 cites W3000283591 @default.
• W4385648859 cites W3025329271 @default.
• W4385648859 cites W3095482252 @default.
• W4385648859 cites W3110093044 @default.
• W4385648859 cites W3122861570 @default.
• W4385648859 cites W3128646645 @default.
• W4385648859 cites W3172717265 @default.
• W4385648859 cites W3196652555 @default.
• W4385648859 cites W4210742966 @default.
• W4385648859 cites W4211123279 @default.
• W4385648859 cites W4285097856 @default.
• W4385648859 cites W4320494348 @default.
• W4385648859 doi "https://doi.org/10.1016/j.breast.2023.08.005" @default.
• W4385648859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37573652" @default.
• W4385648859 hasPublicationYear "2023" @default.
• W4385648859 type Work @default.
• W4385648859 citedByCount "0" @default.
• W4385648859 crossrefType "journal-article" @default.
• W4385648859 hasAuthorship W4385648859A5001910485 @default.
• W4385648859 hasAuthorship W4385648859A5020078965 @default.
• W4385648859 hasAuthorship W4385648859A5031414207 @default.
• W4385648859 hasAuthorship W4385648859A5035471408 @default.
• W4385648859 hasAuthorship W4385648859A5038355731 @default.
• W4385648859 hasAuthorship W4385648859A5039980470 @default.
• W4385648859 hasAuthorship W4385648859A5041668420 @default.
• W4385648859 hasAuthorship W4385648859A5046959234 @default.
• W4385648859 hasAuthorship W4385648859A5079560019 @default.
• W4385648859 hasAuthorship W4385648859A5083047069 @default.
• W4385648859 hasBestOaLocation W43856488592 @default.
• W4385648859 hasConcept C120665830 @default.
• W4385648859 hasConcept C121332964 @default.
• W4385648859 hasConcept C121608353 @default.
• W4385648859 hasConcept C126322002 @default.
• W4385648859 hasConcept C143998085 @default.
• W4385648859 hasConcept C2778292576 @default.
• W4385648859 hasConcept C2779786085 @default.
• W4385648859 hasConcept C2781164504 @default.
• W4385648859 hasConcept C530470458 @default.
• W4385648859 hasConcept C535046627 @default.
• W4385648859 hasConcept C61511704 @default.
• W4385648859 hasConcept C71924100 @default.
• W4385648859 hasConcept C72563966 @default.
• W4385648859 hasConcept C88879693 @default.
• W4385648859 hasConceptScore W4385648859C120665830 @default.
• W4385648859 hasConceptScore W4385648859C121332964 @default.
• W4385648859 hasConceptScore W4385648859C121608353 @default.
• W4385648859 hasConceptScore W4385648859C126322002 @default.
• W4385648859 hasConceptScore W4385648859C143998085 @default.
• W4385648859 hasConceptScore W4385648859C2778292576 @default.
• W4385648859 hasConceptScore W4385648859C2779786085 @default.

• next